# OnCo record tax-327 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tax-327/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tax-327" ;
  schema:name "TAX 327"@en ;
  schema:alternateName "TAX327"@en, "TAX 327 study"@en ;
  schema:description "The trial that first showed any drug could make men with hormone-resistant prostate cancer live longer. The gain was about two and a half months, and it also reduced pain."@en ;
  schema:url <https://onco.cc/trials/tax-327/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa040720>, <https://www.nice.org.uk/guidance/ta101> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/mitoxantrone/>, <https://onco.cc/drugs/prednisone/> ;
  onco:companies <https://onco.cc/companies/sanofi/>, <https://onco.cc/companies/cctg/> ;
  onco:terms <https://onco.cc/terms/castration-resistance/>, <https://onco.cc/terms/psa50/>, <https://onco.cc/terms/qol-pro/>, <https://onco.cc/terms/mcrpc-mhspc/> ;
  onco:trials <https://onco.cc/trials/swog-9916/>, <https://onco.cc/trials/tropic/>, <https://onco.cc/trials/chaarted/> .